Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by balainon Nov 29, 2015 7:33pm

211 Views

Post# 24336933

RE:RE:BMO Margin account

Hi pierre013,

the first time we went over the $2 mark, BMO made them marginable, but when we went under the $2 mark, they took the margin away. Since we climbed fairly fast since the sub $2, I wanted to double check that they made them marginable again.

can you confirm that they are currently marginable?

thanks much

balain

Bullboard Posts

Revolutionizing medical imaging with nanocarbon-based contrast drugs